Gotham Asset Management, LLC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1510387 NEW YORK, NY

Position in AUPH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,177,624

-$320,998 QoQ

Shares Held

128,322

-23.9% QoQ

Ownership

0.096%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#68

of 279 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Gotham Asset Management, LLC holds $433,918,027 across 48 Biotechnology names. AUPH ranks #17 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	719,545	$81,567,621
2	REGN	Regeneron Pharmaceuticals, Inc.	105,165	$65,574,584
3	HALO	Halozyme Therapeutics, Inc.	739,273	$57,862,897
4	EXEL	Exelixis, Inc.	892,663	$48,569,793
5	ROIV	Roivant Sciences Ltd.	1,349,465	$47,757,566
6	JAZZ	Jazz Pharmaceuticals plc	112,014	$26,992,013
7	RVMD	Revolution Medicines, Inc.	120,702	$22,605,070
8	ALNY	Alnylam Pharmaceuticals, Inc.	42,051	$12,658,612

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,177,624	128,322	-23.9%	Shares	Sole	2026-08-14
2026-03-31	$2,498,622	168,598	+32.4%	Shares	Sole	2026-05-15
2025-12-31	$2,031,822	127,387	+57.7%	Shares	Sole	2026-02-17
2025-09-30	$892,320	80,753	-8.7%	Shares	Sole	2025-11-14
2025-06-30	$749,518	88,491	+6.6%	Shares	Sole	2025-08-14
2025-03-31	$667,609	83,036	+84.5%	Shares	Sole	2025-05-15
2024-12-31	$404,064	44,996	+8.8%	Shares	Sole	2025-02-14
2024-09-30	$303,029	41,341	+2.6%	Shares	Sole	2024-11-14
2024-06-30	$230,067	40,292	+1.4%	Shares	Sole	2024-08-14
2023-06-30	$384,615	39,733	-58.1%	Shares	Sole	2023-08-14
2023-03-31	$1,039,884	94,880	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.